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Abstract
Background: Angiotensinogen (ANG) is a macromolecular precursor of angiotensin, which regulates blood pressure
and electrolyte balance. ANG is specifically cleaved by renin, an aspartic protease, to initiate the angiotensin-processing
cascade. Ovine ANG (oANG) from sheep plasma has been shown to be a better substrate for human renin, and it has
been used in clinical renin assays. To expand the availability of oANG, we aimed to produce milligram levels of
recombinant oANG using an Escherichia coli expression system.
Results: When recombinant oANG was expressed from a T7 promoter in various E. coli strains at 37 °C, it accumulated
in the insoluble fraction. However, by expressing oANG at 37 °C from a tac promoter, which has weaker transcriptional
activity than a T7 promoter, we significantly elevated the ratio of soluble to insoluble recombinant oANG. Using a
novel culturing system and auto-induction culture medium, we purified tac-expressed recombinant oANG to
homogeneity, with a yield of 4.0 mg per liter of culture. Based on size-exclusion gel filtration analysis and dynamic light
scattering analysis, the resulting purified oANG is a monomer in solution. The circular dichroism spectrum of E.
coli-expressed recombinant oANG was similar to that of oANG expressed in CHO cells. Differential scanning
fluorimetry showed that both preparations undergo a two-state transition during thermal denaturation, and the
melting temperatures of recombinant oANG expressed in E. coli and CHO cells were 49.4 ± 0.16 °C and 51.6 ± 0.19 °C,
respectively. The Km values of both oANG preparations were similar; the kcat value of E. coli-expressed recombinant
oANG was slightly higher than that of CHO-expressed oANG.
Conclusions: Recombinant oANG expressed in E. coli functions as a human renin substrate. This study presents an E.
coli-based system for the rapid production of milligram quantities of a human renin substrate, which will be useful for
both fundamental and clinical studies on renin and hypertension.
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Background
Angiotensinogen (ANG) is a 452-amino acid plasma glyco-
protein. This protein is specifically cleaved by the aspartic
protease renin (EC 3.4.23.15) to release the N-terminal
decapeptide angiotensin I (AI). AI is further hydrolyzed by
angiotensin-converting enzyme (EC 3.4.15.1) to produce
the octapeptide angiotensin II, which regulates blood
pressure and electrolyte balance [1]. ANG-deficient mice [2]
and renin-deficient mice [3] exhibit profound hypotension,
and no detectable AI was found in the plasma of mice with
either knockout mutation [2, 3]. These in vivo studies
demonstrate the biological importance of enzymatic
cleavage of ANG by renin.
Human renin has a much higher affinity for and shows
a much greater velocity with ovine ANG (oANG) than
human ANG [4–6]. Native oANG, purified from sheep
plasma, has been shown to be a better substrate for human
renin, and it has been used in clinical renin assays [6]. The
purification process for native oANG has been established
[4, 7]: one study reported obtaining approximately 35 mg
of native oANG from 1 L of plasma from a nephrecto-
mized sheep [7]. As an alternative to native oANG, we pre-
pared recombinant oANG using a Chinese hamster ovary
(CHO) cell line that permanently expresses this protein
[8], with a yield of approximately 8 mg purified oANG per
liter of culture medium. Although sheep and a CHO cell
line are effective sources for preparing milligram quantities
of oANG, an animal and cell culture equipment, respect-
ively, are required to produce oANG. Moreover, about one
month of cell culture is required to obtain such amounts
of recombinant oANG. Biotechnological advances that
make it possible to prepare a large amount of oANG
should facilitate clinical studies on renin.
To increase the availability of oANG, we aimed to pro-
duce recombinant oANG using an Escherichia coli ex-
pression system, which makes it possible to express the
protein in a few days. Here, we report an E. coli-based
system for the production of milligram levels of recom-
binant oANG and show that recombinant oANG expressed
in E. coli functions as a human renin substrate.
Results
Expression screening of recombinant oANG in E. coli
As a first step towards expressing recombinant oANG in
E. coli, we compared the effects of different host strains,
induction levels, expression temperatures, and promoters
on the solubility of oANG. Recombinant oANG was
first expressed from an isopropyl-beta-D-thiogalactoside
(IPTG)-inducible T7 promoter at 37 °C in DE3 lysogens of
six tested E. coli strains. Under these conditions, oANG
was found in the insoluble fraction of the cell lysate (Fig. 1a
and c). We also found that E. coli B strains produced more
oANG than E. coli K strains (Fig. 1a and c). When we re-
duced the expression temperature to 25 °C, no significant
band corresponding to oANG was detected on a CBB
stained SDS-polyacrylamide gel (Fig. 1b). Western blotting
showed that when expressed at 25 °C, a small portion of
the total oANG was located in the soluble fraction of
the BL21(DE3), Rosetta 2(DE3), Tuner(DE3), and SHuffle
T7 Express Competent (SHB) E. coli cell lysates (Fig. 1d).
These results suggest that reducing the expression
temperature facilitated proper folding, which yielded a
higher amount of soluble oANG.
The tac promoter is a hybrid of the lac and trp pro-
moters, and its transcriptional activity is weaker than
that of the T7 promoter [9]. To produce soluble oANG
at high yield, we expressed His-tagged oANG from an
IPTG-inducible tac promoter at 37 °C in E. coli BL21
cells. To examine the amount of soluble oANG, we puri-
fied it from the supernatant of the cell lysate using Ni-
affinity chromatography. The bound fraction contained a
protein band with an estimated molecular weight that is
similar to that of oANG (Additional file 1). This protein
was identified as oANG by peptide mass fingerprinting
using matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry. Next, we compared the effect
of promoters on the solubility of recombinant oANG.
When expressed from a T7 promoter, oANG accumulated
in the insoluble fraction, and only a small proportion of
oANG was located in the soluble fraction (Fig. 2a). In
contrast, the soluble to insoluble ratio was approximately
1:1 when oANG was expressed from the tac promoter
(Fig. 2a). These results indicate that expression from a
weaker promoter (i.e., the tac promoter) increased the
ratio of soluble to insoluble recombinant oANG.
Purification of recombinant oANG expressed in E. coli
To prepare a larger amount of oANG, we harvested cell
pellets (wet weight: 45 g) from a 15-L batch culture of E.
coli BL21 cells harboring pTAC-oANG-His. After three
successive chromatography steps, including a Ni-affinity
column, an ion-exchange column, and a gel filtration
column, approximately 0.27 mg of purified His-tagged
oANG was obtained per liter of culture. When reacted
with human renin, this preparation produced AI, indicat-
ing that the purified oANG is a functional renin substrate.
To increase the yield of soluble, active oANG, we uti-
lized both auto-induction culture medium and a novel
culture system to express His-tag-fused oANG from a tac
promoter at 30 °C in E. coli BL21 cells. The absorbance of
the culture medium at 600 nm (OD600) was approximately
15, indicating the high efficiency of this culture system.
Using the three chromatographic steps described above,
oANG was purified to homogeneity according to SDS-
PAGE (Fig. 2b). Its molecular weight was estimated to be
50 k, which is similar to its calculated molecular mass
(50.3 kDa).
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The specific amount in the final preparation was
23.5 μg of AI/mg of total protein. Assuming a molecular
mass of 50.3 kDa for oANG and that one mole of oANG
yields one mole of AI with a molecular mass of
1.296 kDa, the theoretical specific amount of ANG is
25.8 μg of AI/mg. Based on this value, the purity of the
final preparation was 91 %. The production yield was
approximately 4.0 mg of purified oANG per liter of cul-
ture, although 0.5 L of culture (cell pellet wet weight:
8.7 g) was routinely used for oANG production. On the
other hand, the production yield using CHO cells was
approximately 2.3 mg of purified oANG per liter of cul-
ture. In the following analyses, recombinant oANG
expressed in E. coli (oANGEcoli) was compared with
that expressed in CHO cells (oANGCHO).
Protein size analysis of recombinant oANG
To examine the molecular size of recombinant oANG, we
used analytical size-exclusion gel filtration and dynamic
light scattering (DLS). The results of size-exclusion gel
filtration showed that both recombinant oANGEcoli
and oANGCHO exhibited one major peak (Fig. 3a). The
apparent molecular weight of recombinant oANGEcoli
was 42 k. In contrast, recombinant oANGCHO eluted
more quickly (Fig. 3a), and its apparent molecular
weight was 56 k. The DLS results (Fig. 3b) showed that
recombinant oANGEcoli and oANGCHO displayed one
size distribution, with 19.1 and 26.5 % polydispersity,
respectively. The hydrodynamic radii of recombinant
oANGEcoli and oANGCHO were estimated to be 3.05 ±
0.58 nm and 3.02 ± 0.80 nm, respectively, corresponding
to globular proteins with molecular masses of 45.7 kDa
and 44.8 kDa, respectively. As the calculated molecular
mass is 50.3 kDa (seeMethods), these results show that re-
combinant oANG is a monomer in solution. This finding
is consistent with our previous report on oANGCHO [10].
Protein structure and stability analysis of recombinant
oANG
Circular dichroism (CD) analysis was carried out to obtain
secondary structural information for recombinant oANG.
The CD spectrum of recombinant oANGEcoli was similar
to that of oANGCHO (Fig. 4a). Recombinant oANGEcoli
was estimated to be composed of 24 % alpha helix and
Fig. 1 Expression screening of recombinant oANG in E. coli. Comparison of oANG expression and solubility using different E. coli (DE3) host strains and
IPTG concentrations at 37 °C (a) and 25 °C (b). Recombinant oANG was expressed from pET-11a-oANG in E. coli (DE3) lysogens following induction with
IPTG (0.1 and 1.0 mM), separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and then stained with Coomassie Brilliant Blue (CBB). Lane M,
molecular marker; lane T, total cell lysate; lane S, soluble fraction; lane I, insoluble fraction. Western blot analysis of oANG expressed at 37 °C (c) and
25 °C (d) induced with IPTG (0.1 mM). Soluble (S) and insoluble (I) fractions of the cell lysates were analyzed by western blotting with an anti-oANG
polyclonal antibody. Molecular markers (M) were visualized by CBB staining. The molecular weights of the marker proteins are shown on the left. The
arrowhead on the right shows the size of oANG
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22 % beta strand. These values are similar to those calcu-
lated from the crystal structure of human angiotensinogen
[PDB ID: 2WXW], which is composed of 28 % alpha helix
and 23 % beta strand.
To examine the stability of recombinant oANG, we
used differential scanning fluorimetry (DSF). This method
monitors the thermal unfolding of proteins in the pres-
ence of a hydrophobic fluorescent dye, and then the fluor-
escence intensity is plotted as a function of temperature
[11]. The resulting intensity plot is used to estimate the
melting temperature (Tm). The DSF results (Fig. 4b)
showed that both recombinant oANG products (CHO
and E. coli) undergo a two-state transition during the
course of thermal denaturation. The Tm of recombinant
oANGEcoli and oANGCHO was 49.4 ± 0.16 °C and 51.6 ±
0.19 °C, respectively (Fig. 4c).
Human renin reactivity
To determine whether the catalytic efficiency of recom-
binant oANGEcoli is comparable to oANGCHO, we car-
ried out a steady-state kinetic analysis using both oANG
preparations. Both exhibited a typical substrate saturation
curve (Fig. 5). The Michaelis constant (Km) values of the
two preparations were similar, whereas the catalytic turn-
over (kcat) of oANGEcoli was slightly higher than that of
oANGCHO (Table 1). The order of magnitude of the
catalytic efficiency (kcat/Km) for the two preparations is
in good agreement with that of a previous study by
Nakagawa et al. [12].
Discussion
ANG has significant sequence homology to representa-
tive members of the serine protease inhibitor (serpin)
superfamily [13]. Various recombinant serpins have been
produced in E. coli [14]. When expressed in E. coli, some
serpins are soluble, while others become insoluble and
require refolding [14]. Kunapuli et al. [15] purified human
ANG expressed from an IPTG-inducible lac promoter in
E. coli. This preparation was cleaved by human kidney
renin, as assessed by SDS-PAGE and western blotting;
however, its enzymatic characterization was not reported
[15]. Zou et al. [16] expressed recombinant human,
mouse, and rat ANGs in E. coli using a SUMO-fusion
Fig. 3 Protein size analysis of recombinant oANGEcoli and oANGCHO.
The sizes of oANGEcoli (solid line) and oANGCHO (dotted line) were
determined by analytical size-exclusion gel filtration (a) and DLS (b).
Purified oANG was loaded onto a Superdex 200 10/300 GL column
equilibrated with 2 mM HEPES and 0.20 M KCl (pH 8.0). The elution
volumes of the marker proteins are shown. The calibration curve is
shown in the inset. DLS data were measured at 25 °C in a pH 7.4
buffer solution containing 0.5 mg/mL oANG, 20 mM sodium phosphate,
and 20 mM (oANGEcoli) or 33 mM (oANGCHO) KCl. The size distribution
by percent volume is presented
Fig. 2 SDS-PAGE analysis of recombinant oANG expressed from a
tac promoter. a Comparison of recombinant oANG expressed from
either a T7 promoter or a tac promoter. Recombinant oANG expression
was induced with IPTG (0.1 mM) at 37 °C. E. coli cells transformed with
either pET-11a-oANG (T7 promoter) or pTAC-oANG-His (tac promoter)
were diluted to a similar OD600 value and disrupted by sonication.
Recombinant oANG in the soluble (S) and insoluble (I) fractions
was visualized by western blotting. Lane C, control preparation of
oANG produced by pTAC-oANG-His. b SDS-PAGE analysis of the
purified recombinant oANG preparations. The pooled fractions after
each purification step were separated by SDS-PAGE and stained with
CBB. Lane M, molecular weight marker; lane 1, cell lysate; lane 2,
supernatant of cell lysate; lane 3, precipitant of cell lysate; lane 4, pooled
fractions after Ni-NTA Superflow Cartridge column chromatography;
lane 5, after HiTrapQ HP column chromatography; lane 6, after HiLoad
16/60 Superdex 200 pg column chromatography. Molecular weights of
the marker proteins are shown on the left. Arrowhead on the right
shows the size of oANG
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system. According to the data deposited in the Protein
Data Bank [PDB ID: 2WXW], a pSUMO3 plasmid with a
T7 promoter was used to express human ANG. The au-
thors characterized the enzymatic properties of human
ANG and successfully determined the crystal structures of
human, mouse, and rat ANG as well as a renin-ANG
complex [16]. This report shows that the combination of
E. coli and the SUMO-fusion system is a good choice for
expressing recombinant ANG; however, the details of the
expression and purification conditions are not available
[16]. In the present study, a procedure was developed
to prepare milligram quantities of recombinant oANG
expressed in E. coli.
When recombinant oANG was expressed from a T7
promoter at 37 °C in various E. coli strains, it accumu-
lated in the insoluble fraction (Fig. 1a and c). The
breakthroughs in this study were (a) the use of a tac
promoter and (b) the combination of a novel culture
Fig. 4 Protein structure and stability analysis of recombinant oANGEcoli
and oANGCHO. Purified oANGEcoli (solid line) and oANGCHO (dotted line)
were analyzed by CD (a) and DSF (b). CD data were measured at 25 °C
in a pH 7.4 buffer solution containing 0.5 mg/mL oANG, 20 mM
sodium phosphate, and 20 mM (oANGEcoli) or 33 mM (oANGCHO) KCl.
DSF data were measured with 10 μM oANG in 5× SYPRO Orange,
200 mM HEPES, and 0.15 M KCl (pH 7.5). Five typical plots for each
preparation are shown. c Comparison of the Tm of oANGEcoli and
oANGCHO. Tm values are plotted as open circles. The horizontal line and
error bars are the mean value and standard deviation of the Tm values,
respectively (oANGEcoli, N = 30; oANGCHO, N = 31). *P < 0.0001 by
Student’s t-test
Fig. 5 Kinetic analysis of human renin with recombinant oANGEcoli
and oANGCHO. Renin activity in the presence of oANGEcoli (solid line)
and oANGCHO (dotted line) was analyzed by steady-state enzyme
kinetics. Various concentrations of oANG were incubated with human
renin (25 pM) at 37 °C in sodium phosphate buffer (pH 7.2) containing
DFP and EDTA. The amount of AI produced was measured by
enzyme-linked immunosorbent assay (ELISA). The error bars represent
the standard deviation of the velocities (N = 3)
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system and auto-induction culture medium. The former
and the latter were shown to be useful in previous reports
by Ikeda-Boku et al. [17] and Li et al. [18], respectively.
When the protein was expressed from a tac promoter at
37 °C, the ratio of soluble to insoluble recombinant oANG
increased significantly (Fig. 2a), and 4.0 mg of recombin-
ant oANG was prepared from a 15-L culture of E. coli.
Although a milligram amount of oANG was obtained
using this procedure, the production yield was relatively
low (0.27 mg of oANG per liter of culture). With an
aim to develop a higher-yield method, we devised a novel
culture system in which E. coli cells were grown in culture
medium that was aerated and agitated in a glass bottle. In
addition, we used auto-induction medium [19] in which E.
coli cells initiate recombinant protein expression from a
lac-based promoter when they switch carbon sources
from glucose to lactose. As a result, the production yield
increased by a factor of 15, from 0.27 mg to 4.0 mg of
oANG per liter of culture. These breakthroughs enabled
us to prepare a milligram quantity of oANG on a small
culture scale.
We compared the biophysical and enzymatic properties
of recombinant oANGEcoli and oANGCHO. The proteins
in both oANG preparations are a similar size (as estimated
by DLS; Fig. 3b) and have similar secondary structural
elements (Fig. 4a), a two-state transition during thermal
denaturation (Fig. 4b), a similar affinity for human renin
(Km value, Table 1), and a similar catalytic efficiency (kcat/
Km, Table 1). These results strongly suggest that the three-
dimensional structure of recombinant oANGEcoli is very
similar to that of oANGCHO. Although the transcription,
translation, and post-translational modifications of pro-
teins differ between E. coli and CHO cells, recombinant
oANGEcoli must be properly folded since, according to
Anfinsen’s dogma [20], the amino acid sequence of a
protein is sufficient to determine its three-dimensional
fold. In summary, these results show that recombinant
oANG expressed in E. coli is functionally comparable
to oANG expressed in CHO cells.
Recombinant oANGCHO possesses a single N-linked
oligosaccharide chain [10]. On the other hand, recom-
binant oANGEcoli does not have the oligosaccharide chain
because standard E. coli cells do not attach oligosaccharide
chains to N-linked glycosylation sites [21]. The absence of
the N-linked oligosaccharide on oANGEcoli may be the
cause of its lower Tm value (Fig. 4c).
Compared in terms of “production yield divided by
expression days,” the E. coli-based and CHO-based pro-
duction systems produced 2.0 and 0.077 mg oANG/liter
of culture/day of culture, respectively. Therefore, the E.
coli-based production system developed in this study is
26 times more time efficient than the CHO-based
system.
Conclusions
We developed an E. coli expression system that enables
the rapid and easy production of recombinant oANG pro-
tein and successfully prepared 4.0 mg of purified oANG per
liter of culture medium. Recombinant oANG expressed in
E. coli functions as a human renin substrate. Plasma renin
concentration (PRC) is used as a clinical parameter related
to hypertension [6]. This newly developed E. coli expres-
sion system makes human renin substrate more available,
which will be useful for clinical studies on renin.
Methods
Construction of expression plasmid
The oANG gene was amplified by polymerase chain re-
action (PCR) from a pcDNA3 mammalian expression
vector harboring oANG cDNA [8]. The sequences of the
forward and reverse primers were 5′-ATATATATcatatg
GACCGCGTATACATCCACCCCTTCCACCTC-3′
(NdeI site in lower case) and 5′-ATTTggatccTTATTAC
TCAGCGCTCAGCGGGCG-3′ (BamHI site in lower case),
respectively. The pET-11a vector (Novagen, Madison, WI)
and the amplified DNA fragment containing oANG were
digested with NdeI and BamHI and ligated to gener-
ate pET-11a-oANG. The encoded protein comprises
453 amino acids residues (49.2 kDa), including the
mature angiotensinogen (D25-E476) of oANG [GenBank:
BAA04470] [22] and an N-terminal M extension (derived
from the initiation codon).
To produce an oANG expression plasmid with the
protein under the control of the tac promoter, a pTAC-
MAT-Tag vector (Sigma-Aldrich, St. Louis, MO) was
modified by adding a new restriction enzyme site to the
multiple cloning site. The oANG gene was amplified by
PCR from pET-11a-oANG. The sequences of the forward
and reverse primers were 5′-GGGGTCTAGAcatatgGAC
CGCGTATACATCCACCCCTTC-3′ (NdeI site in lower
case) and 5′-GGGGAAGCTTctcgagCTCAGCGCTCAG
CGGGC-3′ (XhoI site in lower case), respectively. The
amplified fragment and the pTAC vector were digested
with NdeI and XhoI. The DNA fragment containing
oANG was sub-cloned into the NdeI and XhoI sites of the
pTAC vector to produce pTAC-oANG-His. The encoded
protein comprises 461 amino acids residues (50.3 kDa),
including the mature angiotensinogen (D25-E476) [22]
Table 1 Kinetic parameters of recombinant oANGEcoli and
oANGCHO




a 0.071 0.59 8.3 × 106
oANGCHO
a 0.072 0.46 6.4 × 106
oANGCHO
b 0.090 0.31 3.4 × 106
aThis work
bNakagawa et al. [12]
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as well as an N-terminal M extension (derived from the ini-
tiation codon) and a C-terminal extension (LEHHHHHH).
Expression of recombinant oANG in E. coli
The pET-11a-oANG plasmid was used to transform six
different E. coli host strains: BL21(DE3), Rosetta 2(DE3),
Tuner(DE3), HMS174(DE3) (Novagen), SHuffle T7 Ex-
press Competent E. coli (SHB), and SHuffle T7 Competent
E. coli (SHK) (New England Biolabs, Herts, UK). Ten ran-
domly selected colonies were suspended in 0.05 mL of LB
medium (Nacalai, Kyoto, Japan), and 0.02 mL of the
suspensions were added to 2 mL of LB medium supple-
mented with either 50 μg/mL ampicillin [all host strains
except for Rosetta 2(DE3)] or 50 μg/mL ampicillin and
25 μg/mL chloramphenicol [Rosetta 2(DE3)]. After the
transformed cells were grown at 37 °C to mid-log phase
(OD600 approximately 0.6), IPTG was added to the culture
medium and protein expression was induced for 3 h.
IPTG concentrations and expression temperatures were
varied in an attempt to improve the solubility of oANG.
Cells were collected by centrifugation (2,200 × g, 10 min,
4 °C), resuspended in phosphate-buffered saline (10 mM
Na2HPO4, 1.8 mM KH2PO4, 140 mM NaCl, and 2.7 mM
KCl, pH 7.3), and disrupted by sonication. The soluble
and insoluble fractions were separated by centrifugation
(13,200 × g, 15 min, 4 °C). All samples were analyzed by
SDS-PAGE in 12 % gels using either CBB staining or west-
ern blotting with rabbit anti-oANG polyclonal anti-serum
(1:10,000 dilution) as a primary antibody [8]. In the
western blot, the antigen-antibody complex was tagged
using an anti-rabbit secondary antibody conjugated
with a horseradish peroxidase and was detected by a
chromogenic reaction using hydrogen peroxide and
3,3′-diaminobenzidine.
To examine the effect of the promoter, BL21(DE3) cells
and BL21 cells were transformed with pET-11a-oANG
and pTAC-oANG-His, respectively. Ten randomly selected
colonies of each transformant were cultured in 2 mL of LB
medium at 37 °C, and recombinant oANG expression was
induced at 37 °C by the addition of 0.1 mM IPTG for 3 h.
The harvested cells were suspended in 1 mL of Buffer A
(20 mM Tris-HCl, 0.3 M KCl, and 1 mM MgCl2, pH 7.6).
The OD600 value of E. coli cells transformed with pET-11a-
oANG (containing a T7 promoter) was 0.81, whereas that
of cells transformed with pTAC-oANG-His (containing a
tac promoter) was 0.79. After disrupting the E. coli cells by
sonication, the soluble and insoluble fractions were pre-
pared for western blotting.
Expression of recombinant oANG in E. coli
E. coli BL21 cells were transformed with the pTAC-
oANG-His plasmid. Ten randomly selected colonies were
suspended and cultured in 2 mL of LB medium supple-
mented with 50 μg/mL ampicillin. After the transformed
cells were grown at 37 °C to mid-log phase (OD600 ap-
proximately 0.6), a culture aliquot was inoculated into
0.5 L of Overnight Express Instant TB medium (Novagen)
[19] supplemented with 50 μg/mL ampicillin, 1 % glycerol,
and 0.01 % Antifoam SI (Wako, Osaka, Japan). The cells
were grown for 16 h at 30 °C using a novel culture system,
aerated at 1 volume of air per unit volume of medium per
min, and agitated at 600 rpm with a magnetic stirrer bar
(ϕ 8 mm, length 60 mm) in a 2-L glass bottle. Cells were
collected by centrifugation (10,000 × g, 10 min, 4 °C) using
a high-speed refrigerated centrifuge (Model 6000; Kubota,
Japan). The cell pellets were stored at -80 °C until use.
About 2 days were required for this E. coli-based expres-
sion of oANG.
Purification of recombinant oANG expressed in E. coli
(oANGEcoli)
Approximately 8 g of E. coli cells were suspended in
100 mL of Buffer A. After the addition of 3 μL of 30
KU/μL rLysozyme (Novagen) and 3 μL of 25 U/μL Ben-
zonase (Novagen), the cell suspension was incubated on
ice for 30 min with gentle stirring. The cells were disrupted
by sonication using an ultrasonic homogenizer (Microson
XL2000; MISONIX). The cell lysate was centrifuged at
14,000 × g for 30 min at 4 °C, and the resulting supernatant
was centrifuged again at 20,000 × g for 15 min at 4 °C. The
clear supernatant was loaded onto a 1-mL Ni-NTA Super-
flow Cartridge column (Qiagen, Venlo, The Netherlands)
equilibrated with Buffer A on an ÄKTAprime plus (GE
Healthcare, Buckinghamshire, England). After washing
with 0.01 M imidazole in Buffer A, proteins were eluted
with a step-wise gradient (0.01 M–0.2 M) of imidazole in
Buffer A. The Ni-NTA bound fractions were pooled, di-
luted 1:10 with 20 mM Tris-HCl (pH 8.0), and loaded onto
a HiTrapQ HP column (GE Healthcare) equilibrated with
the same buffer. Proteins were eluted with a linear gradient
(0.02 M–0.4 M) of KCl in the same buffer. Bound fractions
were pooled, concentrated using a Vivaspin Turbo 15 with
a molecular cut-off of 10,000 (Sartorius, Goettingen,
Germany), and subjected to gel filtration on a HiLoad 16/
60 Superdex 200 pg column (GE Healthcare) equilibrated
with 2 mM 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesul-
fonic acid (HEPES) and 0.2 M KCl (pH 8.0). The oANG-
containing fractions were pooled and concentrated to
5.0 mg/mL using a Vivaspin Turbo 15. The molar con-
centration of oANG was determined using the molecu-
lar extinction coefficient at 280 nm (39,165 M−1 cm−1),
which was calculated according to the formula provided
by Kuramitsu et al. [23].
Preparation of recombinant oANG expressed in CHO cells
(oANGCHO)
Recombinant oANG was expressed in CHO cells and
purified as described previously [8, 24]. About 30 days
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were required for the CHO cell-based expression of
oANG. Approximately 0.8 L of serum-free culture medium
was collected. Ammonium sulfate was added to the cleared
culture medium to 70 % saturation. After removing most
of the supernatant, the precipitate was collected by centri-
fugation (10,000 × g, 10 min, 4 °C). The precipitate was dis-
solved in 20 mM sodium acetate (pH 5.0) and dialyzed
against the same buffer. The dialysate was centrifuged at
10,000 × g for 10 min at 4 °C to remove the insoluble
material. The clear supernatant was loaded onto a HiTrap
SP FF column (GE Healthcare) equilibrated with 20 mM
sodium acetate (pH 5.0). oANG was eluted with a linear
gradient of NaCl (0–1.0 M) in the same buffer. The bound
fractions were pooled, concentrated using a Vivaspin
Turbo 15, and subjected to gel filtration on a HiLoad
16/60 Superdex 200 pg column (GE Healthcare) equili-
brated with 2 mM HEPES and 0.2 M KCl (pH 8.0). The
oANG-containing fractions were pooled and concentrated
to 3.0 mg/mL using a Vivaspin Turbo 15. The above
molecular extinction coefficient at 280 nm was used to
estimate the molar concentration of oANG.
Preparation of recombinant human renin
Recombinant human prorenin was expressed in CHO cells
and purified as described previously [5]. Approximately 1 L
of serum-free culture medium was collected. Proteins in
the cleared medium were precipitated with ammonium
sulfate at 75 % saturation. The precipitate was dissolved in
20 mM acetate (pH 5.0) and dialyzed against the same buf-
fer. Human prorenin was purified on a Resource S column
(GE Healthcare) with a linear gradient of NaCl (0–1.0 M)
in 20 mM acetate (pH 5.0). Immediately after purification,
fractions containing human prorenin were mixed with
one-tenth volume of 0.1 M Tris (pH 8) to neutralize
the pH. The protein concentration of human prorenin
was determined using a molecular extinction coefficient
at 280 nm of 47,705 M−1cm−1, which was calculated with
the ProtParam tool [25], and the final concentration of
human prorenin was 2.4 μM. Human prorenin was
treated with trypsin to prepare human renin, as described
previously [26].
Protein assay
Total protein concentration was measured as described by
Bradford [27] using bovine serum albumin as a standard.
Angiotensinogen assay
The concentration of recombinant oANG was determined
as described previously [8]. Recombinant oANG was incu-
bated with excess human renin at 37 °C for 30 and 45 min
in 5 mM sodium phosphate buffer (pH 7.2) containing
5 mM diisopropyl fluorophosphates (DFP), 5 mM EDTA,
100 mM NaCl, and 0.1 % (w/v) heat-denatured bovine
serum albumin (fraction V). The amount of AI generated
was measured in triplicate by AI-ELISA [28]. The plateau
amount of AI generated was represented as the concentra-
tion of recombinant oANG.
Size-exclusion gel filtration analysis
Purified oANG was subjected to gel filtration on a
Superdex 200 10/300 GL column (GE Healthcare) equil-
ibrated with 2 mM HEPES and 0.20 M KCl (pH 8.0) at a
flow rate of 0.3 mL/min. The column was calibrated
using the Gel Filtration Standard (Bio-Rad Laboratories,
Hercules, CA). The calibration curve is represented by
the equation Kav = 1.9754 - 0.3211(log10Mw), where Kav
is the gel-phase distribution coefficient and Mw is the
molecular weight of the protein.
DLS analysis
The DLS experiments were performed at 25 °C with a
Zetasizer Nano-ZS (Malvern, Worcestershire, UK). Recom-
binant oANG preparations were diluted to a final concen-
tration of 0.5 mg/mL with 20 mM sodium phosphate
(pH 7.4), and the oANGEcoli and oANGCHO preparations
contained 20 and 33 mM KCl, respectively. Prior to the
measurements, the samples were filtered (Ultrafree-MC,
0.22 μm, Millipore). The polydispersity, hydrodynamic
radius, and empirically estimated molecular mass were
calculated using the Zetasizer software provided by the
manufacturer. The hydrodynamic radius was reported
as the mean ± standard deviation. The viscosity and re-
fractive index values of the solvent used were 0.9056 cP
and 1.331, respectively, as calculated by the software.
CD spectroscopic analysis
CD spectra were recorded at 25 °C on a J-820 spectropo-
larimeter (Jasco International, Tokyo, Japan) equipped
with a Peltier thermoregulation system using 1-mm
thick quartz cells (S11-UV-10; GL Sciences). Recombin-
ant oANG preparations were diluted to a final concen-
tration of 0.5 mg/mL with 20 mM sodium phosphate
(pH 7.4), and the oANGEcoli and oANGCHO preparations
contained 20 and 33 mM KCl, respectively. Prior to the
measurements, the samples were filtered (Ultrafree-MC,
0.22 μm, Millipore). CD spectra between 190 and 260 nm
were measured with a scanning speed of 50 nm/min and a
data pitch of 0.2 nm. Spectra from eight scans were aver-
aged. The contribution of buffer was subtracted from each
spectrum. Mean residue ellipticity values were calculated
assuming that the number of residues in oANGEcoli and
oANGCHO was 461 and 452, respectively. The experimen-
tal data in the 200 nm–240 nm range were analyzed by
the K2D3 web server [29] to estimate the secondary struc-
ture content.
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DSF analysis
DSF experiments were performed as described previously
[11]. Recombinant oANG preparations were diluted in
200 mM HEPES and 0.15 M KCl (pH 7.5) to a final con-
centration of 20 μM. The fluorescent dye SYPRO Orange
(Life Technologies, Carlsbad, CA) was diluted to 10×
(from a 5000× stock). Recombinant oANG (20 μM) and
SYPRO Orange (10×) were mixed in a 1:1 ratio. The
mixture was aliquoted into a 96-well PCR plate and sealed
with optical quality sealing film (Applied Biosystems,
Foster City, CA). Thermal unfolding was carried out using
a StepOnePlus real-time PCR instrument (Applied
Biosystems) by heating from 25 to 95 °C at a rate of 1 °C
per min. Fluorescence intensity was measured every 1 °C
using a ROX filter at excitation and emission wavelengths
of 490 and 600 nm–630 nm, respectively. Fluorescence
intensities in relative fluorescence units were plotted as
a function of temperature. To estimate the Tm, the
Boltzmann equation was used to fit the fluorescence
data using GraphPad Prism 5.0 software (GraphPad
Software, La Jolla, CA) and the calculation templates
downloaded from ftp://ftp.sgc.ox.ac.uk/pub/biophysics/
[11]. The Tm values were reported as the mean ± stand-
ard deviation. Student’s t-test was used to statistically
analyze the results.
Kinetic analysis
Various concentrations (0–0.4 μM) of recombinant oANG
were incubated with human renin (25 pM) at 37 °C for
30 min in 5 mM sodium phosphate buffer (pH 7.2)
containing 8 mM DFP, 8 mM EDTA, 100 mM NaCl,
and 0.1 % (w/v) heat-denatured bovine serum albumin
(fraction V). The rate of AI generation was determined
by AI-ELISA [28]. The Km and maximum velocity (Vmax)
were estimated by Hanes-Woolf plot using GraphPad
Prism 5.0 software.
Availability of data and material
The datasets supporting the conclusions of this article
are included within the article and its additional file.
Additional file
Additional file 1: Purification of recombinant oANG using Ni-affinity
column chromatography. (PDF 64 kb)
Abbreviations
AI: angiotensin I; ANG: angiotensinogen; CBB: Coomassie Brilliant Blue;
CD: circular dichroism; CHO: Chinese hamster ovary; DFP: diisopropyl
fluorophosphates; DLS: dynamic light scattering; DSF: differential scanning
fluorimetry; ELISA: enzyme-linked immunosorbent assay; HEPES: 2-[4-(2-
hydroxyethyl)-1-piperazinyl]ethanesulfonic acid; IPTG: isopropyl-beta-D-
thiogalactoside; kcat: catalytic turnover; kcat/Km: catalytic efficiency;
Km: Michaelis constant; oANG: ovine ANG; oANGCHO: ovine angiotensinogen
expressed in CHO cells; oANGEcoli: ovine angiotensinogen expressed in E. coli;
PRC: plasma renin concentration; SDS-PAGE: SDS-polyacrylamide gel
electrophoresis; serpin: serine protease inhibitor; SHB: SHuffle T7 Express
Competent E. coli; SHK: SHuffle T7 Competent E. coli; Tm: melting temperature.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SY designed the study, analyzed the data, and wrote the paper. NS performed
the work and analyzed the data. ABI demonstrated the efficacy of a tac promoter
and performed the preliminary protein characterization demonstrating that
recombinant oANG is produced in an active form in E. coli. EA, AI, TYa, and AH
prepared the protein and performed the characterization. KI and TT established
our laboratory protocol for DSF. SI led the DLS experiments and analyzed the
data. SO, TYo, and KN helped design the oANG expression procedure and
guided the work by ABI, who made the breakthrough in the protein production
of oANG. KBB and AHMNN led the renin activity measurement using oANG. TN
and FS continuously provided scientific and technical comments on this study.
AE conceived the study, participated in its design and coordination, and helped
draft the manuscript. All authors edited the manuscript and approved the final
manuscript.
Acknowledgements
We thank Dr. Frank H. Niesen for providing the calculation template for DSF
and Professor Makoto Kiso for his helpful comments. We also thank Ms.
Keico Nakahara for technical support with protein expression and purification.
This work was supported in part by a grant from Mr. Kiyomi Yoshizaki, by grants
from Gifu University (KASSEIKA KEIHI) and the United Graduate School of
Agricultural Science, Gifu University (WAKATE KASSEIKA KEIHI), and by the JSPS
KAKENHI (Grant Nos. 24658092 and 15 K01707).
Author details
1United Graduate School of Agricultural Science, Gifu University, 1-1
Yanagido, Gifu 501-1193, Japan. 2Graduate School of Applied Biological
Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan. 3Faculty of
Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan. 4Faculty of
Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193,
Japan. 5Department of Biochemistry and Molecular Biology, University of
Dhaka, Dhaka-1000, Bangladesh.
Received: 24 November 2015 Accepted: 30 March 2016
References
1. Campbell DJ. The renin-angiotensin and the kallikrein-kinin systems. Int J
Biochem Cell Biol. 2003;35:784–91.
2. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A,
Murakami K. Angiotensinogen-deficient mice with hypotension. J Biol Chem.
1994;269:31334–7.
3. Yanai K, Saito T, Kakinuma Y, Kon Y, Hirota K, Taniguchi-Yanai K, Nishijo N,
Shigematsu Y, Horiguchi H, Kasuya Y. Renin-dependent cardiovascular
functions and renin-independent blood-brain barrier functions revealed
by renin-deficient mice. J Biol Chem. 2000;275:5–8.
4. Skinner SL, Dunn JR, Mazzetti J, Campbell DJ, Fidge NH. Purification, properties
and kinetics of sheep and human renin substrates. Aust J Exp Biol Med Sci.
1975;53:77–88.
5. Nasir UM, Takahashi K, Nagai T, Nakagawa T, Suzuki F, Nakamura Y. Two peaks
in pH dependence of renin-angiotensinogen reaction. Biosci Biotechnol
Biochem. 1998;62:338–40.
6. Campbell DJ, Nussberger J, Stowasser M, Danser AH, Morganti A, Frandsen E,
Menard J.Activity assays and immunoassays for plasma renin and prorenin:
information provided and precautions necessary for accurate measurement.
Clin Chem. 2009;55:867–77.
7. Fernley RT, John M, Niall HD, Coghlan JP. Purification and characterization
of ovine angiotensinogen. Eur J Biochem. 1986;154:597–601.
8. Nagase M, Suzuki F, Sawai Y, Orihashi T, Inui Y, Nakagawa T, Nakamura Y.
Purification and some properties of recombinant sheep angiotensinogen
expressed in Chinese hamster ovary cells. Biomedical Research-Tokyo. 1997;18:
439–43.
9. Terpe K. Overview of bacterial expression systems for heterologous protein
production: from molecular and biochemical fundamentals to commercial
systems. Appl Microbiol Biotechnol. 2006;72:211–22.
Yamashita et al. BMC Biotechnology  (2016) 16:33 Page 9 of 10
10. Ebihara A, Kondou T, Mizuno S, Nakagawa T, Nasir UM, Inui Y, Fukamizu A,
Suzuki F, Nakamura Y, Murakami K. Molecular properties of recombinant ovine
angiotensinogen. Biomedical Research-Tokyo. 2000;21:247–54.
11. Niesen FH, Berglund H, Vedadi M. The use of differential scanning fluorimetry
to detect ligand interactions that promote protein stability. Nat Protoc.
2007;2:2212–21.
12. Nakagawa T, Nishiuchi K, Akaki J, Iwata H, Satou R, Suzuki F, Nakamura Y.
Efficient production of recombinant human (pro)renin utilizing a
decahistidine tag attached at the C-terminus. Biosci Biotechnol Biochem.
2007;71:256–60.
13. Doolittle RF. Angiotensinogen is related to the antitrypsin-antithrombin-
ovalbumin family. Science. 1983;222:417–9.
14. Bird PI, Pak SC, Worrall DM, Bottomley SP. Production of recombinant
serpins in Escherichia coli. Methods. 2004;32:169–76.
15. Kunapuli SP, Prasad GL, Kumar A. Expression of human angiotensinogen
cDNA in Escherichia coli. J Biol Chem. 1987;262:7672–5.
16. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PL, Stein PE,
Broughton Pipkin F, Read RJ. A redox switch in angiotensinogen
modulates angiotensin release. Nature.
2010;468:108–11.
17. Ikeda-Boku A, Ohno S, Hibino Y, Yokogawa T, Hayashi N, Nishikawa K. A
simple system for expression of proteins containing 3-azidotyrosine at a
pre-determined site in Escherichia coli. J Biochem. 2013;153:317–26.
18. Li Z, Carstensen B, Rinas U. Smart sustainable bottle (SSB) system for E. coli
based recombinant protein production. Microb Cell Factories. 2014;13:153.
19. Grabski A, Mehler M, Drott D. The overnight express autoinduction system:
high-density cell growth and protein expression while you sleep. Nat Methods.
2005;2:233–5.
20. Anfinsen CB. Principles that govern the folding of protein chains. Science.
1973;181:223–30.
21. Jaffe SR, Strutton B, Levarski Z, Pandhal J, Wright PC. Escherichia coli as a
glycoprotein production host: recent developments and challenges. Curr
Opin Biotechnol. 2014;30:205–10.
22. Nagase M, Suzuki F, Fukamizu A, Takeda N, Takeuchi K, Murakami K,
Nakamura Y. Sequencing and expression of sheep angiotensinogen cDNA.
Biosci Biotechnol Biochem. 1994;58:1884–5.
23. Kuramitsu S, Hiromi K, Hayashi H, Morino Y, Kagamiyama H. Pre-steady-state
kinetics of Escherichia coli aspartate aminotransferase catalyzed reactions
and thermodynamic aspects of its substrate specificity. Biochemistry.
1990;29:5469–76.
24. Ebihara A, Nasir UM, Yoshida S, Kondou T, Nakagawa T, Fukamizu A, Suzuki
F, Nakamura Y, Murakami K. Sialic acid residue of ovine angiotensinogen
does not affect the reactivity to human renin. Biomedical Research-Tokyo.
2000;21:105–9.
25. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins M, Appel R, Bairoch A.
Protein Identification and Analysis Tools on the ExPASy Server. In: Walker J,
editor. The proteomics protocols handbook. Totowa: Humana Press; 2005. p.
571–607.
26. Suzuki F, Nakagawa T, Kakidachi H, Murakami K, Inagami T, Nakamura Y. The
dominant role of the prosegment of prorenin in determining the rate of
activation by acid or trypsin: studies with molecular chimeras. Biochem
Biophys Res Commun. 2000;267:577–80.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding. Anal
Biochem. 1976;72:248–54.
28. Suzuki F, Yamashita S, Takahashi A, Ito M, Miyazaki S, Nagata Y, Nakamura Y.
Highly sensitive microplate-ELISA for angiotensin I using
3,3'5,5'tetramethylbenzidine. Clin Exp Hyper. 1990;A12:83–95.
29. Louis-Jeune C, Andrade-Navarro MA, Perez-Iratxeta C. Prediction of protein
secondary structure from circular dichroism using theoretically derived
spectra. Proteins. 2012;80:374–81. •  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Yamashita et al. BMC Biotechnology  (2016) 16:33 Page 10 of 10
